semaglutide in chronic kidney disease Semaglutide: A Breakthrough for FDA approves Ozempic to reduce

10.1016/j.conb.2009.05.001 162

2 These agents are useful against dyskinesia, dystonia, and motor fluctuations, but they carry a higher risk of nonmotor side effects, such as sleepiness, postural hypotension, peripheral edema, and neuropsychiatric issues, compared with levodopa

These approaches give you and your doctor a chance to monitor how your hunger, weight and metabolic markers respond

Then the company posts results of the testing on their website for reference

CONCERN #11: COMPROMISED IMMUNE FUNCTION Description: You seem to catch every cold and bug that goes around, and it takes you longer to shake it than anyone else

Serious concerns with unregulated/high-dose use: infections from non-sterile settings, kidney or liver stress at very high doses over time, and (rarely) thyroid disruption